Patents by Inventor Rafael Rosell Costa

Rafael Rosell Costa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF DETERMINING OUTCOME OF NON SMALL-CELL LUNG CANCER ACCORDING TO XRCC3 POLYMORPHISM
    Publication number: 20070196840
    Abstract: Method for determining a platinum-based chemotherapeutic regimen for treating Non-Small-Cell Lung cancer (NSCLC) in a patient comprising: a) determining the presence or absence of the XRCC3 MetMet polymorphism in a biological sample from the patient, c) determining a a platinum-based chemotherapeutic regimen based on the presence or absence of the XRCC3 MetMet polymorphism in the sample.
    Type: Application
    Filed: January 10, 2007
    Publication date: August 23, 2007
    Inventors: Miguel Taron Roca, Rafael Rosell Costa
  • Device for assaying polymorphisms of gene xpd/ercc2 for the correct administration of chemotherapy for lung cancer
    Publication number: 20060148736
    Abstract: The invention is encompassed in the technical sector of lung cancer treatment with antitumor drugs, and it specifically develops a diagnostic device which allows treating each patient with the most effective drug according to the polymorphism they show for the XPD gene. The assay device of the invention is based on the polymorphic variants of the XPD gene at exon 23 (A-C, Lys 751 Gln) and at exon 10 (G-A, Asp312Asn) and on the development of specific primers which allow detecting said polymorphisms by PCR or by means of automatic DNA sequencing.
    Type: Application
    Filed: December 29, 2003
    Publication date: July 6, 2006
    Inventors: Rafael Rosell Costa, Miguel Taron Roca